Krishna Institute Of Medical Sciences Limited · NSE:KIMS
Krishna Institute Of Medical Sciences — Q3 FY26 Earnings Presentation
32 slides from Krishna Institute Of Medical Sciences's earnings presentation, Feb 6, 2026
Slide 1: Stock exchange cover letter for investor presentation
06th February 2026 The General Manager, The Manager, Department of Corporate Services Listing Department Bombay Stock Exchange Ltd (BSE) National Stock Exchange of India Limited, Phiroze Jheejheebhoy Towers, Exchange Plaza, 5th Floor, Dalal Street, Plot No.C/1, 'G' Block, Mumbai - 400 001. Bandra -
Slide 2: Investor Presentation
Investor Presentation February 06, 2026 Private & Confidential
Slide 3: Disclaimer
Disclaimer This presentation has been prepared by Krishna Institute of Medical Sciences Limited (the “Company”) solely for informational purposes. It should not be construed as an offer, solicitation, or recommendation to purchase or subscribe for any securities of the Company or its affiliates. The
Slide 4: Driven by a Vision
Driven by a Vision Affordable Quality Care VISION: Best-in-Class Facilities Patient Centric Systems & Processes S To be the most preferred NT healthcare services brand by TIE providing affordable care and best PA clinical outcomes to patients. Clinical Outcome Driven Excellence And to be the best pl
Slide 5: Multi Specialty Care
Multi Specialty Care Brain Eyes Bones and Spine Radiology • Neurology • Ophthalmology • Orthopedics • Imaging • Neurosurgery Gastro Intestinal Tract • Arthroscopic Surgery • Interventional Radiology • Psychiatry • Medical Gastroenterology • Spine Surgery Lab Services • Neuro Rehabilitation • Surgica
Slide 6: Dr. B. Bhaskar Rao - Visionary Behind KIMS
Dr. B. Bhaskar Rao - Visionary Behind KIMS Chairman & Managing Director A legend in CT Surgery, Dr. Bollineni Bhaskar Rao {MBBS, MS, DNB (CT Surgery)} is one of the very few Cardio- Thoracic Surgeons in the country, who performed over 30000 surgeries in his career spanning over more than 25 years. W
Slide 7: Dr. Abhinay Bollineni
Dr. Abhinay Bollineni Chief Executive Officer Dr. Abhinay Bollineni joined KIMS Hospitals in 2013 and spent the next couple of years in Hospital Operations before taking charge of Strategy & Marketing for the Group in 2015. He was appointed as the CEO in 2019. Dr. B. Abhinay completed MBBS from the
Slide 8: Board of Directors
Board of Directors Dr. Bhaskara Rao Bollineni Dr. Abhinay Bollineni Mrs. Anitha Dandamudi Mr. Saumen Chakraborty Chairman & Managing Director Chief Executive Officer Whole-time Director Independent Director, Chairman (Audit Committee) Mr. Adwik Bollineni Mr. Venkata Ramudu Jasthi Mrs. Y. Prameela Ra
Slide 9: Shareholding Pattern - As on 31 December, 2025
Shareholding Pattern - As on 31 December, 2025 th Retail & Others, Retail Pre IPO, 9.9% Top Institutional Share Holders 6.7% Share Holder Share Holding % Promoters, 34.1% SBI MF 6.0% Axis MF 4.8% HDFC MF 4.3% FII, 16.1% Invesco MF 3.6% Kotak Fund 3.0% Nomura 2.9% Vanguard Equity Funds 2.3% SBI Insur
Slide 10: Modern Medical Technology
Modern Medical Technology 4-Arm HD da Vinci MrGFUS Focussed Tulsa-Pro System Robotic Surgical Ultrasound A non- invasive procedure that System Revolutionary Knifeless Brain uses real-time MRI guidance Facilitates complex surgeries procedure for treating tremors. to precisely deliver thermal that are
Slide 11: Many Firsts...
Many Firsts... • First in Asia in to do Trans catheter • India’s first COVID Double Lung • Number 1 in Nephrology treatments in Tricuspid Valve replacement transplant done in 2020 Andhra Pradesh* procedure done in 2018 • India’s first Breathing Lung transplant • Number 1 in Neurosurgery & Poly • Lar
Slide 12: Key Accomplishments
Key Accomplishments NAL ACCRED TIO IT NA AT ER ION INT QU Y ET LI AF A TY & PAT I E N T S Pharmacie De Qualite (PDQ) American Accreditation Commission Certification Overall PDQ Evaluation ‘Best Patient Friendly Hospital’ NABH Digital Standards Accreditation Ranked No. 1 Hospital International (AACI)
Slide 13: Consistent Performer over 2 decades
Consistent Performer over 2 decades (Rupees in Millions) 30,670 7,590 25,143 6,200 22,235 5,766 .7% : 2 9 26 .9% 16,711 GR G R : CA 5,217 CA 11,287 2,412 4,280 773 1,311 317 263 42 2005 2010 2015 2020 2022 2023 2024 2025 2005 2010 2015 2020 2022** 2023 2024 2025 No. of No. of No. of No. of No. of No
Slide 14: KIMS Journey: From Regional Leader to National Healthcare Roadmap
KIMS Journey: From Regional Leader to National Healthcare Roadmap Overall Bed Capacity of 9100+ Beds Year Andhra Pradesh Telangana Maharashtra Kerala Karnataka Tamil Nadu 2000 Nellore - 250 2001 Rajahmundry - 195 2004 Secunderabad - 1000 2011 Srikakulam - 300 2014 Kondapur - 220 2017 Ongole - 350 20
Slide 15: KIMS Journey: Strategic Levers for Future Growth
KIMS Journey: Strategic Levers for Future Growth Consistent Growth Over Two Decades Achieved 27%+ CAGR in Revenue and 30% CAGR in EBITDA, reflecting sustained operational excellence and strategic expansion. Delivering high-quality care through affordable healthcare models, advanced These transplant
Slide 16: Q3 FY26 Updates
Q3 FY26 Updates 15 Private & Confidential
Slide 17: Financial & Operational Highlights - 1/2
Financial & Operational Highlights - 1/2 (Rupees in Millions) Financial Highlights Particulars Q3 FY26 Q2 FY26 Q3 FY25 QoQ(%) YoY(%) 9M FY25 9M FY26 YoY(%) Operating Revenue 9,977 9,607 7,724 3.9% 29.2% 22,381 28,300 26.4% Other Income 52 42 178 23.8% -70.8% 274 165 -39.8% Total Revenue 10,029 9,649
Slide 18: Financial & Operational Highlights - 2/2
Financial & Operational Highlights - 2/2 Operational Highlights Particulars Q3 FY26 Q2 FY26 Q3 FY25 QoQ YoY IP Volume 61,139 64,288 54,013 -4.9% 13.2% OP Volume 585,491 592,725 470,159 -1.2% 24.5% ARPOB (Rs) 46,341 42,016 38,472 10.3% 20.5% ARPP (Rs) 164,232 150,624 144,181 9.0% 13.9% 17 Private & C
Slide 19: Group Operating Performance
Group Operating Performance IP VOLUME (‘000) OP VOLUME (‘000) 14.6% (4.9%) 6.6% (1.2%) 183 64 1,294 593 61 470 585 54 159 1,214 9MFY25 9MFY26 Q3 FY25 Q2 FY26 Q3 FY26 9MFY25 9MFY26 Q3 FY25 Q2 FY26 Q3 FY26 OCCUPIED BEDS / OCCUPANCY %* ARPOB (‘000) 14.0% 10.3% 2,402 2,510 43.8 46.0 2,362 38.4 42.0 2,26
Slide 20: Group Operating and Financial Performance
Group Operating and Financial Performance Particulars FY25 9M FY25 9M FY26 Q3 FY25 Q2 FY26 Q3 FY26 Bed Capacity# 5,179 4,859 6,464 4,859 6,114 6,464 Operational Beds 4,239 4,089 4,825 4,089 4,695 4,825 Census Beds 3,633 3,477 3,973 3,477 3,883 3,973 Non Census Beds 606 612 852 612 812 852 Occupied B
Slide 21: Group Financial Performance
Group Financial Performance (Rupees in Millions) TOTAL REVENUE EBITDA 3.9% (2.0%) 25.6% 0.0% 28,465 10,029 6,120 2,082 9,649 6,121 2,050 2,041 7,902 22,655 9MFY25 9MFY26 Q3 FY25 Q2 FY26 Q3 FY26 9MFY25 9MFY26 Q3 FY25 Q2 FY26 Q3 FY26 PBT* PAT* (34.2%) (32.3%) (27.9%) 4,240 1,346 (29.1%) 3,087 925 968
Slide 22: Operational and Financial Performance - 1/2
Operational and Financial Performance - 1/2 Telangana Andhra Pradesh Particulars FY25 9M FY25 9M FY26 Q3 FY25 Q2 FY26 Q3 FY26 FY25 9M FY25 9M FY26 Q3 FY25 Q2 FY26 Q3 FY26 Bed Capacity 1,797 1,797 1,882 1,797 1,882 1,882 2214 2214 2314 2214 2314 2314 Operational Beds 1,682 1,682 1,694 1,682 1,694 1,6
Slide 23: Operational and Financial Performance - 2/2
Operational and Financial Performance - 2/2 Maharashtra Kerala Karnataka Group Particulars FY25 9M FY25 9M FY26 Q3 FY25 Q2 FY26 Q3 FY26 FY25 9M FY25 9M FY26 Q3 FY25 Q2 FY26 Q3 FY26 9M FY26 Q2 FY26 Q3 FY26 FY25 9M FY25 9M FY26 Q3 FY25 Q2 FY26 Q3 FY26 Bed Capacity 659 659 959 659 959 959 509 189 509 1
Slide 24: Ramp-up of Kerala Units
Ramp-up of Kerala Units (Rupees in Millions) Kannur EBITDA Positive Kollam 275.2 179.7 272.4 253.6 152.2 87.3 28.0 12.4 11.8 (35.9) (21.1) (15.8) Q1FY26 Q2FY26 Q3FY26 Q1FY26 Q2FY26 Q3FY26 NABH - Entry level NABH - In Pipeline Robotic Milestone: First robotic renal transplant in North Malabar. Emerge
Slide 25: Ramp-up of Maharashtra Units
Ramp-up of Maharashtra Units (Rupees in Millions) Nashik Thane 195.3 428.8 176.4 152.5 298.1 55.8 (97.9) (64.7) (38.2) (92.3) (150.0) (76.1) Q1FY26 Q2FY26 Q3FY26 Q1FY26 Q2FY26 Q3FY26 NABH - Entry level NABH - In Pipeline Tertiary Care Expansion: Launch advanced specialties - Paediatric Cardiac Surge
Slide 26: Ramp-up of AP & Karnataka Units
Ramp-up of AP & Karnataka Units (Rupees in Millions) Vizag QNRI Mahadevapura (Bengaluru) Electronic City (Bengaluru) 268.3 308.0 36.0 238.9 214.0 23.5 29.0 14.6 (0.3) 0.0 (182.8) (96.1) (70.6) (164.2) Q1FY26 Q2FY26 Q3FY26 Q2FY26 Q3FY26 Q2FY26 Q3FY26 NABH - Accredited NABH - In Pipeline NABH - In Pip
Slide 27: Ramp-up of O&M Units
Ramp-up of O&M Units (Rupees in Millions) Sangli EBITDA Positive Guntur EBITDA Positive 247.6 243.4 230.8 252.9 235.3 195.0 14.2 13.5 12.3 (22.5) (30.9) 1.9 Q1FY26 Q2FY26 Q3FY26 Q1FY26 Q2FY26 Q3FY26 NABH - Entry level NABH - In Pipeline Consultant Model Optimization: Transitioned FFS consultants to
Slide 28: Revenue Mix & Cluster Profile (Group 9M FY26)
Revenue Mix & Cluster Profile (Group 9M FY26) SPECIALITY MIX PAYOR MIX CLUSTER TOTAL REVENUE Kerala 4.3% Karnataka Maharashtra Aarogyasri 1.3% 11.5% 4% Others Cardiac Sciences 21% 17% Andhra Pradesh Corporate Cash 24.6 13% 53% Telangana 58.3% Renal Sciences 9% Mother & Child 10% Organ Oncology Trans
Slide 29: Key Achievements in Q3 FY26
Key Achievements in Q3 FY26 28 Private & Confidential
Slide 30: Key Achievements in Q3 FY26
Key Achievements in Q3 FY26 29 Private & Confidential
Slide 31: Corporate Structure (As on 31 December'25)
Corporate Structure (As on 31 December'25) st Krishna Institute of Medical Sciences Limited Units Wholly Owned Subsidiaries KIMS Secunderabad KIMS Nellore KIMS Rajahmundry KIMS Ongole KIMS Thane KIMS QNRI KIMS Swastha KHPL (100%) (100%) (100%) (100%) (100%) Visakhapatnam Kerala Rajahmundry (100%) (1
Slide 32: Thank You
Thank You 31 Private & Confidential
Krishna Institute of Medical Sciences — Q3 FY26 Earnings Presentation on 6ix